Fondaparinux Sodium intermediate N3
Pharmaceutical Materials 2025-03-02
Applications in Drug Developmen：
1.Mechanism of Action:
Fondaparinux Sodium is an antithrombin III (ATIII)-dependent factor Xa inhibitor.It selectively binds to ATIII, enhancing its neutralization of factor Xa by about 300 times, thereby inhibiting thrombin generation.
2.Indications:
Used for the prevention and treatment of venous thromboembolic events, such as after hip fractures or knee surgeries.
| Property | Details |
|---|---|
| Name | Fondaparinux Sodium Intermediate N3 |
| CAS No. | 114903-05-8 |
| Molecular Formula | C₈₁H₉₁N₇O₂₇ |
| Molecular Weight | 1594.64 g/mol |
| Appearance | White to off-white solid |
| Purity | ≥98% (HPLC/NMR confirmed) |
| Application | Key intermediate in synthesizing fondaparinux sodium (anticoagulant) |
| Pharmacology | Enhances ATIII inhibition of Factor Xa, disrupting coagulation cascade |
| Synthesis | Involves protection/deprotection steps, sulfation, and catalytic hydrogenation |
| QC Standards | Purity ≥98%, residual solvents <0.5%, heavy metals <10 ppm |
| Storage | -20°C, sealed, moisture-free |
| Packaging | 1g, 5g, 10g, 50g, 1kg (customizable) |
Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.
